1-alkyl-3-thio-substituted indole2-alkynoic acids useful for the treatment for Alzheimer's disease and related conditions

Details for Australian Patent Application No. 2004295154 (hide)

Owner Merck & Co. Inc. Merck Sharp & Dohme Limited

Inventors Prasit, Petpiboon; Stock, Nicholas S.; Wrigley, Jonathan D. J.; Churcher, Ian; Beher, Dirk; Quddus, Abdul; Bettati, Michela; Munzo, Benito

Agent Spruson & Ferguson

Pub. Number AU-A-2004295154

PCT Pub. Number WO2005/054193

Priority 60/526,649 03.12.03 US

Filing date 25 November 2004

Wipo publication date 16 June 2005

International Classifications

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 209/30 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/36 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

8 June 2006 PCT application entered the National Phase

  PCT publication WO2005/054193 Priority application(s): WO2005/054193

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004295155-Packaging and supply of contact lenses

2004295152-A process for resolving, optionally substituted, mandelic acids by salt formation with a chiral base cyclic amide